参考资料:
[1] Beacon Therapeutics Raises $170 Million in Series B Funding to Advance Development of Ophthalmic Gene Therapies. Retrieved July 3, 2024 from https://www.beacontx.com/news-and-events/beacon-therapeutics-raises-170-million-in-series-b-funding-to-advance-development-of-ophthalmic-gene-therapies/<br>